Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.7500 (-0.31%) ($122.7500 - $124.7800) on Wed. Feb. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 66 | Latest Price | $122.7500(-0.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND advances 0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWO(62%) IBB(61%) IWM(60%) IWC(57%) IWN(57%) | Factors Impacting LGND price | LGND will decline at least -1.565% in a week (0% probabilities). VIXM(-28%) UUP(-20%) VXX(-17%) EDOC(-6%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $121.31(1.19%) | 10 Day Moving Average | $121.8(0.78%) | 20 Day Moving Average | $119.76(2.5%) | To recent high | -25.9% | To recent low | 8.8% | Market Cap | $1.973b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |